Application 209936
- Type
- NDA
- Sponsor
- BAYER HEALTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALIQOPA | COPANLISIB DIHYDROCHLORIDE | POWDER;INTRAVENOUS | 60MG/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209936-001 | ALIQOPA | COPANLISIB DIHYDROCHLORIDE | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 |
| N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | |
| N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD | 2017-09-14 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N209936-001 | ALIQOPA | 60MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2017-09-14 | e64feba35796… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209936-001 | 7511041 | 2024-05-13 | Drug substance, Drug product | 2017-10-10 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209936-001 | 7511041 | 2024-05-13 | Drug substance, Drug product | 2017-10-10 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209936-001 | 7511041 | 2024-05-13 | Drug substance, Drug product | 2017-10-10 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209936-001 | 7511041 | 2024-05-13 | Drug substance, Drug product | 2017-10-10 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209936-001 | 7511041 | 2024-05-13 | Drug substance, Drug product | 2017-10-10 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N209936-001 | 10383876 | 2032-03-29 | Drug substance, Drug product | 2019-09-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209936-001 | 9636344 | 2032-03-29 | U-2124 | 2017-10-10 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209936-001 | 7511041 | 2024-05-13 | Drug substance, Drug product | 2017-10-10 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209936-001 | RE46856 | 2029-10-22 | U-2124 | Drug substance, Drug product | 2018-06-15 | 79d66fd596c7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209936-001 | ODE-155 | 2024-09-14 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209936-001 | ODE-155 | 2024-09-14 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209936-001 | ODE-155 | 2024-09-14 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209936-001 | ODE-155 | 2024-09-14 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N209936-001 | ODE-155 | 2024-09-14 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209936-001 | ODE-155 | 2024-09-14 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209936-001 | ODE-155 | 2024-09-14 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209936-001 | ODE-155 | 2024-09-14 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N209936-001 | ODE-155 | 2024-09-14 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209936-001 | NCE | 2022-09-14 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209936-001 | ODE-155 | 2024-09-14 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N209936-001 | NCE | 2022-09-14 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N209936-001 | ODE-155 | 2024-09-14 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N209936-001 | NCE | 2022-09-14 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N209936-001 | ODE-155 | 2024-09-14 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N209936-001 | NCE | 2022-09-14 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N209936-001 | ODE-155 | 2024-09-14 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N209936-001 | NCE | 2022-09-14 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N209936-001 | ODE-155 | 2024-09-14 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N209936-001 | NCE | 2022-09-14 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N209936-001 | ODE-155 | 2024-09-14 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209936-001 | NCE | 2022-09-14 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209936-001 | ODE-155 | 2024-09-14 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N209936-001 | NCE | 2022-09-14 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N209936-001 | ODE-155 | 2024-09-14 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N209936-001 | NCE | 2022-09-14 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N209936-001 | ODE-155 | 2024-09-14 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N209936-001 | NCE | 2022-09-14 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N209936-001 | ODE-155 | 2024-09-14 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N209936-001 | NCE | 2022-09-14 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N209936-001 | ODE-155 | 2024-09-14 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N209936-001 | NCE | 2022-09-14 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N209936-001 | ODE-155 | 2024-09-14 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N209936-001 | NCE | 2022-09-14 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N209936-001 | ODE-155 | 2024-09-14 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N209936-001 | ODE-155 | 2024-09-14 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N209936-001 | ODE-155 | 2024-09-14 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N209936-001 | ODE-155 | 2024-09-14 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N209936-001 | ODE-155 | 2024-09-14 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N209936-001 | ODE-155 | 2024-09-14 | 9b2671bbb829… |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-385 | ALIQOPA | copanlisib | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 75375 | SUPPL | 2023-09-08 |
| 75369 | SUPPL | 2023-09-07 |
| 73915 | SUPPL | 2023-03-31 |
| 73911 | SUPPL | 2023-03-31 |
| 70258 | SUPPL | 2022-02-25 |
| 70241 | SUPPL | 2022-02-24 |
| 61885 | SUPPL | 2020-02-13 |
| 61878 | SUPPL | 2020-02-13 |
| 60706 | SUPPL | 2019-10-29 |
| 60698 | SUPPL | 2019-10-29 |
| 58937 | SUPPL | 2019-06-04 |
| 58872 | SUPPL | 2019-05-29 |
| 50061 | ORIG | 2017-10-16 |
| 49731 | ORIG | 2017-09-14 |
| 49730 | ORIG | 2017-09-14 |